ED
TCOM icon

Exane Derivatives’s Trip.com Group TCOM Stock Holding History

Exane Derivatives’s Portfolio TCOM Stock Details TCOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,382
Closed -$78.2K – 917
2022
Q1 		$78.2K Buy
+3,382
New +$85.2K 0.02% 506
2021
Q4 		– Sell
-1,297
Closed -$39.9K – 967
2021
Q3 		$39.9K Hold
1,297
– – 0.01% 642
2021
Q2 		$41.7K Sell
1,297
-4,429
-77% -$169K 0.01% 658
2021
Q1 		$227K Sell
5,726
-108
-2% -$4K 0.06% 281
2020
Q4 		$197K Buy
5,834
+453
+8% +$14.8K 0.06% 313
2020
Q3 		$168K Sell
5,381
-5,157
-49% -$147K 0.05% 225
2020
Q2 		$273K Buy
+10,538
New +$266K 0.07% 198
2015
Q2 		– Sell
-1,480
Closed -$43.4K – 552
2015
Q1 		$43.4K Buy
+1,480
New +$35.7K ﹤0.01% 324

Other funds holding TCOM

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.52B AUM 10.48% 1-Year Est. Return

Exane Derivatives's TCOM Position: Q2 2022 in Review

Exane Derivatives sold out of Trip.com Group (TCOM) in Q2 2022, closing a stake of 3,382 shares — an estimated $78.2K sold.

Exane Derivatives first reported a position in TCOM in Q1 2015 and held it in 8 quarters. The position peaked at $273K in Q2 2020. 315 funds tracked by Wall St. Rank hold TCOM as of Q2 2022.

  • Exane Derivatives reported no remaining Trip.com Group position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 3,382 Trip.com Group shares in Q2 2022, an estimated $78.2K.
  • Exane Derivatives first reported a position in Trip.com Group in Q1 2015 and held it in 8 quarters.
  • Exane Derivatives's Trip.com Group position peaked at $273K in Q2 2020.
  • 315 funds tracked by Wall St. Rank held Trip.com Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.